Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proliferative assays for T cell function.

Ada M Kruisbeek1, Ethan Shevach, Angela M Thornton

  • 1Netherlands Cancer Institute, Amsterdam, The Netherlands.

Current Protocols in Immunology
|April 25, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eos plays a critical role in Treg homeostasis and modulates the function of recirculating thymic Tregs in the control of Treg development.

Cell reports·2025
Same author

Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunity.

Research square·2025
Same author

Illuminating T cell-dendritic cell interactions in vivo by FlAsHing antigens.

eLife·2024
Same author

Transfer of Cellular Content from the Allogeneic Cell-Based Cancer Vaccine DCP-001 to Host Dendritic Cells Hinges on Phosphatidylserine and Is Enhanced by CD47 Blockade.

Cells·2021
Same author

Helios represses megakaryocyte priming in hematopoietic stem and progenitor cells.

The Journal of experimental medicine·2021
Same author

Corrigendum to "Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity" [J. Autoimmun. 105C (2019) 102300].

Journal of autoimmunity·2020
Same journal

A Comprehensive Experimental Guide to Studying Cross-Presentation in Dendritic Cells In Vitro.

Current protocols in immunology·2020
Same journal

Immunologic Studies in Humans.

Current protocols in immunology·2020
Same journal

Immunologic Studies in Humans.

Current protocols in immunology·2020
Same journal

Immunologic Studies in Humans.

Current protocols in immunology·2020
Same journal

Monoclonal Antibodies to Human Cell Surface Antigens.

Current protocols in immunology·2020
Same journal

Protocols for Experimental Sjögren's Syndrome.

Current protocols in immunology·2020
See all related articles

This study details assays for evaluating CD4+CD25+ T cell function and suppressive capabilities. It outlines methods to induce proliferation and assess their regulatory role in immune responses.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • CD4+CD25+ T cells, a distinct subset of T lymphocytes, exhibit unique regulatory properties.
  • Unlike conventional T cells, they do not proliferate readily to T cell receptor (TCR) stimulation alone.

Purpose of the Study:

  • To describe methodologies for assessing CD4+CD25+ T cell non-responsiveness and function.
  • To detail assays for evaluating the suppressive capacity of CD4+CD25+ T cells.
  • To outline protocols for activating and expanding CD4+CD25+ T cells in culture.

Main Methods:

  • Assays to evaluate CD4+CD25+ T cell non-responsiveness and function.
  • Co-culture assays with conventional T cells to assess suppressive function.
  • Culture conditions for activation and expansion of CD4+CD25+ T cells.

Related Experiment Videos

Main Results:

  • Specific conditions required to induce proliferation in CD4+CD25+ T cells were identified.
  • Methodologies for assessing the suppressive function of CD4+CD25+ T cells were established.
  • Protocols for the activation and expansion of these regulatory T cells were described.

Conclusions:

  • Standardized assays are crucial for understanding CD4+CD25+ T cell biology.
  • These methods facilitate the study of T cell regulation and immune tolerance.
  • The described protocols support research into the therapeutic potential of CD4+CD25+ T cells.